NOW LOADING

Should You Buy This Blue Chip Tech Stock-TEAM

Acrobull UK Advisory Services Ltd.

 

September 222025
NameTickerSector/IndustryMarket CapRisk Factor 
Atlassian Corporation.TEAM-NASDAQTechnology$44.348 BillionMedium 
       

 

Atlassian Corporation offers a suite of collaboration software designed to connect teams and streamline workflows, enhancing productivity at scale across organizations globally. Its product portfolio includes Jira, a comprehensive project management platform that facilitates the planning, tracking, and management of work.

 

 

Recent Highlights

 

 

  • They successfully closed out fiscal year 2025 with strong financial performance, surpassing $5.2 billion in total revenue, generating over $1.4 billion in free cash flow, and achieving 2.3 million monthly active users of their AI-driven solutions,” stated Mike Cannon-Brookes, CEO and Co-Founder of Atlassian.

 

  • AI is transforming the way teams work, and this shift is driving significant tailwinds for Atlassian. With their industry-leading cloud platform, bolstered by the expansive and dynamic Teamwork Graph, and enhanced by Rovo's cutting-edge AI capabilities, they are uniquely positioned to empower organizations of all sizes. Their solutions are designed to help teams unlock and leverage enterprise knowledge at scale, driving collaboration and innovation across the global workforce.

 

Fourth Quarter 2025 Financial Highlights

 

  • Revenue: Total revenue for the fourth quarter of fiscal year 2025 reached $1,384.3 million, reflecting a 22% increase compared to $1,131.6 million for the same period in fiscal year 2024. This growth highlights the continued strength and demand for Atlassian's product offerings across the global market.

 

  • Operating Loss and Operating Margin: For the fourth quarter of fiscal year 2025, the company reported an operating loss of $28.5 million, a notable improvement compared to an operating loss of $67.0 million in the fourth quarter of fiscal year 2024. The operating margin for this period was (2%), representing a positive shift from the (6%) margin recorded in the same quarter of the previous year, demonstrating progress toward improving operational efficiency.

 

 

  • Net Loss and Net Loss Per Diluted Share: Atlassian posted a net loss of $23.9 million for the fourth quarter of fiscal year 2025, a significant reduction from the net loss of $196.9 million for the fourth quarter of fiscal year 2024. On a per-share basis, the net loss per diluted share was $0.09, a substantial improvement compared to a net loss per diluted share of $0.76 for the same period in the prior year. 

 

  • Balance Sheet: As of the end of the fourth quarter of fiscal year 2025, Atlassian reported a strong financial position, with cash and cash equivalents, in addition to marketable securities, totaling $2.9 billion. This solid cash reserve reflects the company’s strong liquidity, providing a strong foundation for continued investment in growth initiatives, strategic acquisitions, and operational flexibility in the years ahead. 

 

Stock Observation- Looking ahead, Atlassian is well-positioned to maintain its growth trajectory, with strong demand for its product offerings continuing to drive revenue expansion. The 22% year-over-year increase in total revenue for the fourth quarter of fiscal year 2025 demonstrates the company's ability to meet the evolving needs of global organizations. As Atlassian further strengthens its product portfolio and leverages emerging technologies like AI, it is poised to capture new opportunities and sustain its momentum in the coming quarters, fueling continued growth and long-term success in the global market.

 

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

 

 
Considering all the factors and financials of the company Acrobull UK maintains Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull UK only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull UK would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull UK is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull UK does not guarantee returns. 

 

 

Acrobull UK Recommendation Based on Evaluation

 

Current Market Price$169.05 USD
Acrobull RecommendationBuy
Target PriceTarget $185.25 USD
RSI Level38
Total Shares Outstanding166.28 Million

Shares Held by Insiders

Shares Held by Institutions

Risk Factor

Stop Loss

0.32%

94.40%

Medium

5%

 

Acro Bull UK Logo

© Copyright Acro Bull UK All Rights Reserved 2025

Accepted Payment Modes